- Home
- MDBH vs PULM Comparison
MDBH vs PULM Comparison
Compare MDBH & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDBH
- PULM
- Stock Information
- Founded
- MDBH 1997
- PULM 2003
- Country
- MDBH United States
- PULM United States
- Employees
- MDBH N/A
- PULM N/A
- Industry
- MDBH
- PULM Biotechnology: Pharmaceutical Preparations
- Sector
- MDBH
- PULM Health Care
- Exchange
- MDBH Nasdaq
- PULM Nasdaq
- Market Cap
- MDBH 39.3M
- PULM 33.2M
- IPO Year
- MDBH 2023
- PULM N/A
- Fundamental
- Price
- MDBH $4.23
- PULM $7.43
- Analyst Decision
- MDBH
- PULM
- Analyst Count
- MDBH 0
- PULM 0
- Target Price
- MDBH N/A
- PULM N/A
- AVG Volume (30 Days)
- MDBH 5.3K
- PULM 34.5K
- Earning Date
- MDBH 08-12-2025
- PULM 08-12-2025
- Dividend Yield
- MDBH N/A
- PULM N/A
- EPS Growth
- MDBH N/A
- PULM N/A
- EPS
- MDBH 0.84
- PULM N/A
- Revenue
- MDBH $3,574,131.00
- PULM $1,921,000.00
- Revenue This Year
- MDBH N/A
- PULM N/A
- Revenue Next Year
- MDBH N/A
- PULM $134.88
- P/E Ratio
- MDBH $5.02
- PULM N/A
- Revenue Growth
- MDBH N/A
- PULM N/A
- 52 Week Low
- MDBH $3.61
- PULM $1.78
- 52 Week High
- MDBH $12.00
- PULM $10.40
- Technical
- Relative Strength Index (RSI)
- MDBH 52.12
- PULM 49.28
- Support Level
- MDBH $3.72
- PULM $8.49
- Resistance Level
- MDBH $4.75
- PULM $8.75
- Average True Range (ATR)
- MDBH 0.12
- PULM 0.42
- MACD
- MDBH 0.07
- PULM -0.14
- Stochastic Oscillator
- MDBH 49.32
- PULM 0.11
About MDBH MDB Capital Holdings LLC common
MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).